by Peter Ciszewski | May 6, 2020
Muthiah Vaduganathan, MD, MPH, cardiologist at Brigham and Women’s Hospital recently cowrote a special report for the New England Journal of Medicine about the use of renin-angiotensin-aldosterone system (RAAS) inhibitors in patients infected with COVID-19. As...
by Peter Ciszewski | May 5, 2020
Angelman syndrome is a rare genetic disorder affecting roughly 500,000 people worldwide. Patients with Angelman syndrome generally experience developmental delays, intellectual disabilities, extensive speech impairment, issues with movement and balance,...
by Peter Ciszewski | May 5, 2020
The US Food and Drug Administration (FDA) has approved Fensolvi (leuprolide acetate) to treat children, two years of age and older, with central precocious puberty. Central precocious puberty is a rare endocrine disorder defined as the onset of puberty before the age...
by Peter Ciszewski | May 4, 2020
Lambert-Eaton myasthenic syndrome is a disorder of the neuromuscular junction. The neuromuscular junction is the site where nerve cells meet muscle cells and help activate the muscles. This syndrome occurs when antibodies interfere with electrical impulses between the...
by Peter Ciszewski | May 4, 2020
The U.S. Food and Drug Administration (FDA) has approved a new subcutaneous formulation of daratumumab (daratumumab and hyaluronidase-fihj or Darzalex Faspro) for five indications in multiple myeloma patients. Daratumumab and hyaluronidase-fihj can be administered...
